Status:
UNKNOWN
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
Lead Sponsor:
Behar, Caren, M.D.
Conditions:
Migraine Disorders
Migraine Headache
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.
Eligibility Criteria
Inclusion
- Established diagnosis of Migraine as per IHS with aura
- Established diagnosis of Migraine as per IHS without aura
- At least 2 migraines per month
- At least 18 years of age
Exclusion
- Pregnancy or Lactation
- Other Headache Conditions including basilar, hemiplegic, or ophthalmoplegic migraines
- Chronic Daily Headache
- Allergy or Sensitivity to NSAIDs
- Other Severe Medical Conditions including GI bleeding, blood dyscrasias, thrombocytopenia
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01228552
Start Date
December 1 2011
End Date
January 1 2012
Last Update
June 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Medical College
Valhalla, New York, United States, 10595